Gene Panel Market

Gene Panel Market Size, Share & Trends Analysis Report

Gene Panel Market Size, Share, Statistics & Trends Analysis Report By Product type Analysis (Kits, Services) By Approach analysis (Amplicon based, Hybridization based) By Application analysis (Cancer Risk Assessment, Syndrome-Specific, High-Penetrance Gene Panel, High- And Moderate Penetrance Genes, Comprehensive Cancer Panels, Diagnosis of Congenital Diseases, Pharmacogenomics, Others) By End User Analysis (Hospitals, Diagnostic Laboratories, Research and Academic Institutes) Based On Region, And Segment Forecasts, 2022 - 2028

Report ID : BMRC 54
Number of pages : 300
Published Date : Nov 2022
Category : Pharmaceutical
Delivery Timeline : 48 hrs

Gene Panel Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028. Increase in cancer research and rise in demand of genetic testing are key drivers for Global Gene Panel Market.

Scope of Market Report –

Gene panel testing refers to sequencing multiple pre-specified genes using NGS sequencing platforms. Accelerated development of multigene test panels is having a positive impact on the medical conduct and individualized treatment for patients. According to the International Agency for Research on Cancer, by 2030 there will be over 22 million new cases a year, up from 14 million in 2012. There is a significant rise in prevalence of cancer globally. So, during the study of Global Gene Panel market, we have considered Gene Panel products and consumables to analyze the market.

Global Gene Panel Market report is segmented on the basis of Product type, Approach type, Application Type, End User type and by regional & country level. Based on Product type global Gene Panel Market is classified as Kits and Services. Based upon approach, global Gene Panel Market is classified as Amplicon based and Hybridization based. Based upon Sample type, global Gene Panel Market is classified as Blood, Urine, Serum/Plasma and others. Based upon Application type, global Gene Panel Market is classified as Cancer Risk Assessment, Diagnosis of Congenital Diseases and Others. Based upon End User type, global Gene Panel Market is classified as Hospitals, Diagnostic Laboratories and Research & Academic Institutes.

The regions covered in this Gene Panel Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Gene Panel is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Gene Panel Market Key Players -

  • Illumina, Inc
  • Thermo Fisher Scientific
  • BGI
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ag
  • Integrated DNA Technologies
  • Genewiz, Inc.
  • Archerdx
  • Genedx
  • Oxford Gene Technology
  • Primbio Research Institute
  • Fulgent Genetics
  • Blueprint Genetics
  • Foundation Medicine Inc.
  • Guardant Health, Inc.
  • Myriad Genetic Laboratories Inc.
  • Bio-Rad Laboratories, Inc.

Gene Panel Market Segmentation –

By Product type Analysis

  • Kits
  • Services

By Approach analysis

  • Amplicon based
  • Hybridization based

By Application analysis

  • Cancer Risk Assessment
  • Syndrome-Specific
  • High-Penetrance Gene Panel
  • High- And Moderate Penetrance Genes
  • Comprehensive Cancer Panels
  • Diagnosis of Congenital Diseases
  • Pharmacogenomics
  • Others

By End User Analysis

  • Hospitals
  • Diagnostic Laboratories
  • Research
  • Academic Institutes

By Regional & Country Analysis

North America, US, Mexico, Chily, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, South Korea, Japan, India, Southeast Asia, Latin America, Brazil, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa

Market Dynamics –

Growing awareness about the potential benefits in genetic testing, increasing number of cancer patients, growing research in cancer and other congenital diseases, rising demand for targeted approaches and personalized medicine are the major key drivers for the growth of the Global Gene Panel Market. However, high costs serious doubts among individuals concerning the authenticity of genetic reports are the major restrains of the Global Gene Panel Market. Nonetheless, untapped market and technological advancements may generate new opportunities in forecast period.

Regional Analysis –

North America dominates the market with highest market share due to increasing number of cancer incidences, increasing launch of new and advanced products, government support for genomics research, presence of leading Next Generation Sequencing providers and growing research on cancer. In 2016, total U.S. medical and health Research & Development spending was $171.8 billion .According to NCI (National Cancer Institute), in 2016, there were an estimated 15.5 million cancer survivors in the United States and is expected to increase to 20.3 million by 2026. Europe is the second largest market for Gene Panel Testing. According to the latest report by World Health Organization (WHO), with more than 3.7 million new cases and 1.9 million deaths each year, cancer represents the second most important cause of death and morbidity in Europe. Increasing prevalence of cancer and increased growth in research and development activities are majorly responsible on growth of Gene Panel market in Europe. According to the  latest report by World Health Organization (WHO), Asia Pacific region anticipates to see a 70% increase in new cancer cases in the next two decades. Asia Pacific Gene Panel Market is witnessed with strong growth rate majorly due high prevalence of cancer, increasing population, growing awareness regarding cure and treatment of cancer and government funding for research and development. India and China are potential markets for genetic services, due to increase in the prevalence of infectious diseases.

Report Analysis Details
Historical data 2018-2021
Forecast Period 2022 - 2028
Market Size in 2020:  XX
Base year considered 2021
Forecast Period CAGR %:


Market Size Expected in 2028:  XX
Tables, Charts & Figures: 175
Pages 200

Gene Panel manufacturers

Illumina, Inc, Thermo Fisher Scientific, BGI, Eurofins Scientific, F. Hoffmann-La Roche Ag, Integrated Dna Technologies, Genewiz, Inc., Archerdx, Genedx, Oxford Gene Technology, Primbio Research Institute,Fulgent Genetics, Blueprint Genetics, Foundation Medicine Inc., Guardant Health, Inc., Myriad Genetic Laboratories Inc., Bio-Rad Laboratories, Inc., and others.
Segments Covered By Product type Analysis, By Approach analysis, By Application analysis
Regional Analysis North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits –

  • Global Gene Panel Market report covers in depth historical and forecast analysis.
  • Global Gene Panel Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Gene Panel Market report helps to identify opportunities in market place.
  • Global Gene Panel Market report covers extensive analysis of emerging trends and competitive landscape.